Agency Information Collection Activities; Proposed Collection; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, 6955-6957 [2020-02371]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 25 / Thursday, February 6, 2020 / Notices
Electronic Submissions
agency procedure, the change will be
made without reviewing comments.
Statutory Authority: Section 814 of
the Native American Programs Act of
1974, as amended.
Elizabeth Leo,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration.
[FR Doc. 2020–02319 Filed 2–5–20; 8:45 am]
BILLING CODE 4184–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0118]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Prior Notice of
Imported Food Under the Public Health
Security and Bioterrorism
Preparedness and Response Act of
2002
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing an opportunity for
public comment on the proposed
collection of certain information by the
Agency. Under the Paperwork
Reduction Act of 1995 (PRA), Federal
Agencies are required to publish notice
in the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of our regulations
requiring that the Agency receive prior
notice before food is imported or offered
for import into the United States.
DATES: Submit either electronic or
written comments on the collection of
information by April 6, 2020.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before April 6, 2020.
The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of April 6, 2020. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
lotter on DSKBCFDHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:54 Feb 05, 2020
Jkt 250001
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–N–0118 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Prior
Notice of Imported Food Under the
Public Health Security and Bioterrorism
Preparedness and Response Act of
2002.’’ Received comments, those filed
in a timely manner (see ADDRESSES),
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
6955
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
E:\FR\FM\06FEN1.SGM
06FEN1
6956
Federal Register / Vol. 85, No. 25 / Thursday, February 6, 2020 / Notices
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Prior Notice of Imported Food Under
the Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002—21 CFR 1.278 to
1.285
OMB Control Number 0910–0520—
Extension
lotter on DSKBCFDHB2PROD with NOTICES
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (Bioterrorism Act)
added section 801(m) of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 381(m)), which requires
that FDA receive prior notice for food,
including food for animals, that is
imported or offered for import into the
United States. Sections 1.278 to 1.282 of
FDA regulations (21 CFR 1.278 to 1.282)
set forth the requirements for submitting
prior notice; §§ 1.283(d) and 1.285(j) (21
CFR 1.283(d) and 1.285(j)) set forth the
procedure for requesting Agency review
after FDA has refused admission of an
article of food under section 801(m)(1)
of the FD&C Act or placed an article of
food under hold under section 801(l) of
the FD&C Act; and § 1.285(i) sets forth
the procedure for post-hold
submissions.
Section 304 of the FDA Food Safety
Modernization Act (Pub. L. 111–353)
amended section 801(m) of the FD&C
VerDate Sep<11>2014
19:54 Feb 05, 2020
Jkt 250001
Act to require a person submitting prior
notice of imported food, including food
for animals, to report, in addition to
other information already required,
‘‘any country to which the article has
been refused entry.’’ Advance notice of
imported food allows FDA, with the
support of the U.S. Customs and Border
Protection (CBP), to target import
inspections more effectively and help
protect the nation’s food supply against
terrorist acts and other public health
emergencies. By requiring that a prior
notice contain specific information that
indicates prior refusals by any country
and identifies the country or countries,
the Agency may better identify imported
food shipments that may pose safety
and security risks to U.S. consumers.
This information collection enables
FDA to make better informed decisions
in managing the potential risks of
imported food shipments into the
United States. Any person with
knowledge of the required information
may submit prior notice for an article of
food. Thus, the respondents to this
information collection may include
importers, owners, ultimate consignees,
shippers, and carriers.
FDA regulations require that prior
notice of imported food be submitted
electronically using CBP’s Automated
Broker Interface of the Automated
Commercial System (ABI/ACS)
(§ 1.280(a)(1)) or the FDA Prior Notice
System Interface (PNSI) (Form FDA
3540) (§ 1.280(a)(2)). PNSI is an
electronic submission system available
on the FDA Industry Systems page at
https://www.access.fda.gov/. Information
the Agency collects in the prior notice
submission includes: (1) The submitter
and transmitter (if different from the
submitter); (2) entry type and CBP
identifier; (3) the article of food,
including complete FDA product code;
(4) the manufacturer, for an article of
food no longer in its natural state; (5)
the grower, if known, for an article of
food that is in its natural state; (6) the
FDA Country of Production; (7) the
name of any country that has refused
entry of the article of food; (8) the
shipper, except for food imported by
international mail; (9) the country from
which the article of food is shipped or,
if the food is imported by international
mail, the anticipated date of mailing and
country from which the food is mailed;
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
(10) the anticipated arrival information
or, if the food is imported by
international mail, the U.S. recipient;
(11) the importer, owner, and ultimate
consignee, except for food imported by
international mail or transshipped
through the United States; (12) the
carrier and mode of transportation,
except for food imported by
international mail; and (13) planned
shipment information, except for food
imported by international mail (§ 1.281).
Much of the information collected for
prior notice is identical to the
information collected for FDA
importer’s entry notice, which has been
approved under OMB control number
0910–0046. The information in an
importer’s entry notice is collected
electronically via CBP’s ABI/ACS at the
same time the respondent files an entry
for import with CBP. To avoid doublecounting the burden hours already
counted in the importer’s entry notice
information collection, the burden hour
analysis in table 1 reflects FDA’s
estimate of the reduced burden for prior
notice submitted through ABI/ACS in
column 6 entitled ‘‘Average Burden per
Response.’’
In addition to submitting a prior
notice, a submitter should cancel a prior
notice and must resubmit the
information to FDA if information
changes after the Agency has confirmed
a prior notice submission for review
(e.g., if the identity of the manufacturer
changes) (§ 1.282). However, changes in
the estimated quantity, anticipated
arrival information, or planned
shipment information do not require
resubmission of prior notice after the
Agency has confirmed a prior notice
submission for review (§ 1.282(a)(1)(i) to
(iii)). In the event that FDA refuses
admission to an article of food under
section 801(m)(1) or the Agency places
it under hold under section 801(l) of the
FD&C Act, §§ 1.283(d) and 1.285(j) set
forth the procedure for requesting FDA’s
review and the information required in
a request for review. In the event that
the Agency places an article of food
under hold under § 801(l) of the FD&C
Act, § 1.285(i) sets forth the procedure
for, and the information to be included
in, a post-hold submission.
We estimate the burden of this
collection of information as follows:
E:\FR\FM\06FEN1.SGM
06FEN1
6957
Federal Register / Vol. 85, No. 25 / Thursday, February 6, 2020 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
21 CFR section
Number of
respondents
FDA form No.
Number of
responses per
respondent
Total annual
responses
Average burden per
response
Total hours
Prior Notice Submissions: Through ABI/ACS
1.280 through 1.281 ............
N/A
1,700
7,647
12,999,900
0.167 (10 minutes) .............
2 2,170,983
Through PNSI
1.280 through 1.281 ............
3540 3
27,000
70
1,890,000
0.384 (23 minutes) .............
725,760
Subtotal ........................
........................
........................
........................
........................
.............................................
2,896,743
7,040
0.25 (15 minutes) ...............
1,760
Cancellations: Through ABI/ACS
1.282 ...................................
3540
7,040
1
Through PNSI
1.282 and 1.283(a)(5) .........
3540
35,208
1
35,208
0.25 (15 minutes) ...............
8,802
Subtotal ........................
........................
........................
........................
........................
.............................................
10,562
Requests for Review and Post-hold Submissions
1.283(d) and 1.285(j) ..........
1.285(i) ................................
N/A
N/A
1
263
1
1
1
263
8 .........................................
1 .........................................
8
263
Subtotal ........................
........................
........................
........................
........................
.............................................
271
Total ......................
........................
........................
........................
14,932,412
.............................................
2,907,576
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
avoid double-counting, an estimated 396,416 burden hours already accounted for in the Importer’s Entry Notice information collection approved under OMB control number 0910–0046 are not included in this total.
3 The term ‘‘Form FDA 3540’’ refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov.
lotter on DSKBCFDHB2PROD with NOTICES
2 To
Based on our experience and the
average number of prior notice
submissions, cancellations, and requests
for review received in the past 3 years,
we have made no adjustments in our
burden estimate for the information
collection. We estimate that 1,700 users
of ABI/ACS will submit an average of
7,647 prior notices annually, for a total
of 12,999,900 prior notices received
through ABI/ACS. We assume the
reporting burden for a prior notice
submitted through ABI/ACS to be 10
minutes, or 0.167 hour, per notice, for
a total annual burden of 2,170,983
hours. This estimate takes into
consideration the burden hours already
counted in the information collection
approval for FDA importer’s entry
notice (OMB control number 0910–
0046), as previously discussed.
We estimate that 27,000 registered
users of PNSI will submit an average of
70 prior notices annually, for a total of
1,890,000 prior notices received
annually. We assume the reporting
burden for a prior notice submitted
through PNSI to be 23 minutes, or 0.384
hour, per notice, for a total burden of
725,760 hours.
We estimate that 7,040 users of ABI/
ACS will submit an average of 1
cancellation annually, for a total of
VerDate Sep<11>2014
19:54 Feb 05, 2020
Jkt 250001
7,040 cancellations received annually
through ABI/ACS. We assume the
reporting burden for a cancellation
submitted through ABI/ACS to be 15
minutes, or 0.25 hour, per cancellation,
for a total burden of 1,760 hours.
We estimate that 35,208 registered
users of PNSI will submit an average of
1 cancellation annually, for a total of
35,208 cancellations received annually.
We assume the reporting burden for a
cancellation submitted through PNSI to
be 15 minutes, or 0.25 hour, per
cancellation, for a total burden of 8,802
hours.
We estimate that one or fewer
requests for review under § 1.283(d) or
§ 1.285(j) will be submitted annually.
We assume that it will take respondents
8 hours to prepare the factual and legal
information necessary to prepare a
request for review. Thus, we estimate a
total reporting burden of 8 hours.
We estimate that 263 post-hold
submissions under § 1.285(i) will be
submitted annually. We assume that it
will take about 1 hour to prepare the
written notification described in
§ 1.285(i)(2)(i), for a total reporting
burden of 263 hours.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Dated: January 29, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–02371 Filed 2–5–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–D–3324]
Use of Serological Tests To Reduce
the Risk of Transfusion-Transmitted
Human T-Lymphotropic Virus Types I
and II; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance entitled ‘‘Use of Serological
Tests to Reduce the Risk of TransfusionTransmitted Human T-Lymphotropic
Virus Types I and II (HTLV–I/II).’’ The
guidance document provides blood
collection establishments with
recommendations regarding the use of
SUMMARY:
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 85, Number 25 (Thursday, February 6, 2020)]
[Notices]
[Pages 6955-6957]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02371]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0118]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Prior Notice of Imported Food Under the Public Health
Security and Bioterrorism Preparedness and Response Act of 2002
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
announcing an opportunity for public comment on the proposed collection
of certain information by the Agency. Under the Paperwork Reduction Act
of 1995 (PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the information collection
provisions of our regulations requiring that the Agency receive prior
notice before food is imported or offered for import into the United
States.
DATES: Submit either electronic or written comments on the collection
of information by April 6, 2020.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before April 6, 2020. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of April 6, 2020. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2010-N-0118 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Prior Notice of Imported Food
Under the Public Health Security and Bioterrorism Preparedness and
Response Act of 2002.'' Received comments, those filed in a timely
manner (see ADDRESSES), will be placed in the docket and, except for
those submitted as ``Confidential Submissions,'' publicly viewable at
https://www.regulations.gov or at the Dockets Management Staff between
9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-5733,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an
[[Page 6956]]
existing collection of information, before submitting the collection to
OMB for approval. To comply with this requirement, FDA is publishing
notice of the proposed collection of information set forth in this
document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Prior Notice of Imported Food Under the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002--21 CFR 1.278 to
1.285
OMB Control Number 0910-0520--Extension
The Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 (Bioterrorism Act) added section 801(m) of the
Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 381(m)),
which requires that FDA receive prior notice for food, including food
for animals, that is imported or offered for import into the United
States. Sections 1.278 to 1.282 of FDA regulations (21 CFR 1.278 to
1.282) set forth the requirements for submitting prior notice;
Sec. Sec. 1.283(d) and 1.285(j) (21 CFR 1.283(d) and 1.285(j)) set
forth the procedure for requesting Agency review after FDA has refused
admission of an article of food under section 801(m)(1) of the FD&C Act
or placed an article of food under hold under section 801(l) of the
FD&C Act; and Sec. 1.285(i) sets forth the procedure for post-hold
submissions.
Section 304 of the FDA Food Safety Modernization Act (Pub. L. 111-
353) amended section 801(m) of the FD&C Act to require a person
submitting prior notice of imported food, including food for animals,
to report, in addition to other information already required, ``any
country to which the article has been refused entry.'' Advance notice
of imported food allows FDA, with the support of the U.S. Customs and
Border Protection (CBP), to target import inspections more effectively
and help protect the nation's food supply against terrorist acts and
other public health emergencies. By requiring that a prior notice
contain specific information that indicates prior refusals by any
country and identifies the country or countries, the Agency may better
identify imported food shipments that may pose safety and security
risks to U.S. consumers.
This information collection enables FDA to make better informed
decisions in managing the potential risks of imported food shipments
into the United States. Any person with knowledge of the required
information may submit prior notice for an article of food. Thus, the
respondents to this information collection may include importers,
owners, ultimate consignees, shippers, and carriers.
FDA regulations require that prior notice of imported food be
submitted electronically using CBP's Automated Broker Interface of the
Automated Commercial System (ABI/ACS) (Sec. 1.280(a)(1)) or the FDA
Prior Notice System Interface (PNSI) (Form FDA 3540) (Sec.
1.280(a)(2)). PNSI is an electronic submission system available on the
FDA Industry Systems page at https://www.access.fda.gov/. Information
the Agency collects in the prior notice submission includes: (1) The
submitter and transmitter (if different from the submitter); (2) entry
type and CBP identifier; (3) the article of food, including complete
FDA product code; (4) the manufacturer, for an article of food no
longer in its natural state; (5) the grower, if known, for an article
of food that is in its natural state; (6) the FDA Country of
Production; (7) the name of any country that has refused entry of the
article of food; (8) the shipper, except for food imported by
international mail; (9) the country from which the article of food is
shipped or, if the food is imported by international mail, the
anticipated date of mailing and country from which the food is mailed;
(10) the anticipated arrival information or, if the food is imported by
international mail, the U.S. recipient; (11) the importer, owner, and
ultimate consignee, except for food imported by international mail or
transshipped through the United States; (12) the carrier and mode of
transportation, except for food imported by international mail; and
(13) planned shipment information, except for food imported by
international mail (Sec. 1.281).
Much of the information collected for prior notice is identical to
the information collected for FDA importer's entry notice, which has
been approved under OMB control number 0910-0046. The information in an
importer's entry notice is collected electronically via CBP's ABI/ACS
at the same time the respondent files an entry for import with CBP. To
avoid double-counting the burden hours already counted in the
importer's entry notice information collection, the burden hour
analysis in table 1 reflects FDA's estimate of the reduced burden for
prior notice submitted through ABI/ACS in column 6 entitled ``Average
Burden per Response.''
In addition to submitting a prior notice, a submitter should cancel
a prior notice and must resubmit the information to FDA if information
changes after the Agency has confirmed a prior notice submission for
review (e.g., if the identity of the manufacturer changes) (Sec.
1.282). However, changes in the estimated quantity, anticipated arrival
information, or planned shipment information do not require
resubmission of prior notice after the Agency has confirmed a prior
notice submission for review (Sec. 1.282(a)(1)(i) to (iii)). In the
event that FDA refuses admission to an article of food under section
801(m)(1) or the Agency places it under hold under section 801(l) of
the FD&C Act, Sec. Sec. 1.283(d) and 1.285(j) set forth the procedure
for requesting FDA's review and the information required in a request
for review. In the event that the Agency places an article of food
under hold under Sec. 801(l) of the FD&C Act, Sec. 1.285(i) sets
forth the procedure for, and the information to be included in, a post-
hold submission.
We estimate the burden of this collection of information as
follows:
[[Page 6957]]
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR section FDA form No. Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior Notice Submissions: Through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 through 1.281....................... N/A 1,700 7,647 12,999,900 0.167 (10 minutes).......... \2\ 2,170,983
--------------------------------------------------------------------------------------------------------------------------------------------------------
Through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 through 1.281....................... 3540 \3\ 27,000 70 1,890,000 0.384 (23 minutes).......... 725,760
-------------------------------------------------------------------------------------------------------------
Subtotal.............................. .............. .............. .............. .............. ............................ 2,896,743
--------------------------------------------------------------------------------------------------------------------------------------------------------
Cancellations: Through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282..................................... 3540 7,040 1 7,040 0.25 (15 minutes)........... 1,760
--------------------------------------------------------------------------------------------------------------------------------------------------------
Through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282 and 1.283(a)(5)..................... 3540 35,208 1 35,208 0.25 (15 minutes)........... 8,802
-------------------------------------------------------------------------------------------------------------
Subtotal.............................. .............. .............. .............. .............. ............................ 10,562
--------------------------------------------------------------------------------------------------------------------------------------------------------
Requests for Review and Post-hold Submissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.283(d) and 1.285(j)..................... N/A 1 1 1 8........................... 8
1.285(i).................................. N/A 263 1 263 1........................... 263
-------------------------------------------------------------------------------------------------------------
Subtotal.............................. .............. .............. .............. .............. ............................ 271
-------------------------------------------------------------------------------------------------------------
Total............................. .............. .............. .............. 14,932,412 ............................ 2,907,576
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ To avoid double-counting, an estimated 396,416 burden hours already accounted for in the Importer's Entry Notice information collection approved
under OMB control number 0910-0046 are not included in this total.
\3\ The term ``Form FDA 3540'' refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov.
Based on our experience and the average number of prior notice
submissions, cancellations, and requests for review received in the
past 3 years, we have made no adjustments in our burden estimate for
the information collection. We estimate that 1,700 users of ABI/ACS
will submit an average of 7,647 prior notices annually, for a total of
12,999,900 prior notices received through ABI/ACS. We assume the
reporting burden for a prior notice submitted through ABI/ACS to be 10
minutes, or 0.167 hour, per notice, for a total annual burden of
2,170,983 hours. This estimate takes into consideration the burden
hours already counted in the information collection approval for FDA
importer's entry notice (OMB control number 0910-0046), as previously
discussed.
We estimate that 27,000 registered users of PNSI will submit an
average of 70 prior notices annually, for a total of 1,890,000 prior
notices received annually. We assume the reporting burden for a prior
notice submitted through PNSI to be 23 minutes, or 0.384 hour, per
notice, for a total burden of 725,760 hours.
We estimate that 7,040 users of ABI/ACS will submit an average of 1
cancellation annually, for a total of 7,040 cancellations received
annually through ABI/ACS. We assume the reporting burden for a
cancellation submitted through ABI/ACS to be 15 minutes, or 0.25 hour,
per cancellation, for a total burden of 1,760 hours.
We estimate that 35,208 registered users of PNSI will submit an
average of 1 cancellation annually, for a total of 35,208 cancellations
received annually. We assume the reporting burden for a cancellation
submitted through PNSI to be 15 minutes, or 0.25 hour, per
cancellation, for a total burden of 8,802 hours.
We estimate that one or fewer requests for review under Sec.
1.283(d) or Sec. 1.285(j) will be submitted annually. We assume that
it will take respondents 8 hours to prepare the factual and legal
information necessary to prepare a request for review. Thus, we
estimate a total reporting burden of 8 hours.
We estimate that 263 post-hold submissions under Sec. 1.285(i)
will be submitted annually. We assume that it will take about 1 hour to
prepare the written notification described in Sec. 1.285(i)(2)(i), for
a total reporting burden of 263 hours.
Dated: January 29, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-02371 Filed 2-5-20; 8:45 am]
BILLING CODE 4164-01-P
